In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes . Rev Diabet Stud. 2023;9(4). Accessed September 13, 2025. https://diabeticstudies.org/index.php/RDS/article/view/184